Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.41 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.40 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1703996 | 1.00 | KDM4E (0.60) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL30099173 | 0.98 | KDM4E (0.63) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL30923587 | 0.98 | KDM4E (0.63) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL1695888 | 0.98 | KDM4E (0.63) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL28762308 | 0.98 | KDM4E (0.63) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL579964 | 0.98 | KDM4E (0.63) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL609590 | 0.94 | KDM4E (0.68) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Stearic Acid SCHEMBL30063427 | 0.93 | KDM4E (0.74) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Myristic Acid SCHEMBL8885381 | 0.93 | KDM4E (0.74) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL29791959 | 0.93 | KDM4E (0.74) | KDM4EDUSP3MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 755 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230241194-A1 | PRE-ERYTHROCYTIC MALARIA VACCINES | THEISEN MICHAEL (DK) | 2023-08-03 | — | — | US | claimed |
| WO-2023120447-A1 | STERILIZATION COMPOSITION AND STERILIZATION METHOD | 日油株式会社 | 2023-06-29 | — | — | WO | claimed |
| CN-113286574-B | Cosmetic composition comprising a cosmetic capsule absorbing a water-soluble extract | 韩国科玛株式会社 | 2023-05-30 | — | — | CN | claimed |
| EP-4171630-A1 | PRE-ERYTHROCYTIC MALARIA VACCINES | PATH (US) | 2023-05-03 | — | — | EP | claimed |
| US-20230109998-A1 | MALARIA TRANSMISSION-BLOCKING VACCINES | PATH (US) | 2023-04-13 | — | — | US | claimed |
| CN-115869224-A | Oil-dispersed solid cosmetic composition comprising fermented ceramide butter and preparation method thereof | 科丝美诗株式会社 | 2023-03-31 | — | — | CN | claimed |
| CN-115869208-A | Oil-dispersed solid cosmetic composition containing ascorbic acid and preparation method thereof | 科丝美诗株式会社 | 2023-03-31 | — | — | CN | claimed |
| EP-4126020-A1 | MALARIA TRANSMISSION-BLOCKING VACCINES | PATH (US) | 2023-02-08 | — | — | EP | claimed |
| CN-115209866-A | Mixed cosmetic comprising creamy compacted powder | 艺术化妆品有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-114748392-A | Haematococcus pluvialis extract and application thereof | 艾苛密（上海）健康科技股份有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-113194986-A | Formulations comprising vaccine adjuvants | 大日本住友制药株式会社 | 2021-07-30 | — | — | CN | claimed |
| CN-106999403-B | Composition for external application to skin | 株式会社LG生活健康 | 2021-07-06 | — | — | CN | claimed |
| CN-112912061-A | Long-lasting moisturizing cosmetic compositions | 株式会社LG生活健康 | 2021-06-04 | — | — | CN | claimed |
| CN-112638350-A | Solvent modification of prewetted substrates | GPCP知识产权控股有限责任公司 | 2021-04-09 | — | — | CN | claimed |
| CN-112472620-A | Additive composition for preventing precipitation of vitamin C | 株式会社爱茉莉太平洋 | 2021-03-12 | — | — | CN | claimed |
| CN-111743796-A | Whitening milk and preparation method thereof | 泉后(广州)生物科技研究院有限公司 | 2020-10-09 | — | — | CN | claimed |
| CN-111568797-A | Composition for quickly removing fine lines and application thereof | 泉后(广州)生物科技研究院有限公司 | 2020-08-25 | — | — | CN | claimed |
| WO-2020138217-A1 | PREPARATION INCLUDING VACCINE ADJUVANT | 大日本住友製薬株式会社 | 2020-07-02 | — | — | WO | claimed |
| CN-111343965-A | Cosmetically acceptable anhydrous composition for nail polish | 国际莱克斯 | 2020-06-26 | — | — | CN | claimed |
| US-5637142-A | MIXTURE OF FLUORINE CONTAINING OIL, HYDROCARBON OIL AND POLYMERIC SURFACTANT | DAIKIN INDUSTRIES, LTD. (JP) | 1997-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230109998-A1 | MALARIA TRANSMISSION-BLOCKING VACCINES | GALE, GNE, MGAT3 | KDM4E 79/4885DUSP3 3038/4885MEN1 2095/4885 |
| US-20230241194-A1 | PRE-ERYTHROCYTIC MALARIA VACCINES | CD14, CD47, IL15 | KDM4E 19/4885DUSP3 2679/4885MEN1 2052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.